The largest of the Danish pharmaceutical companies is without doubt Novo Nordisk, whose main area is medicines and treatments for diabetes, with products such as diabetes pens and needles. Diabetes treatment products generated most of Novo Nordisk’s sales, but they also focus on areas such as hormone replacement therapy and pharmaceuticals for treatment of other serious chronic diseases, like obesity, haemophilia, growth disorders.
Novo Nordisk’s annual net profit increased every year during the last ten years, and the company is also the largest employer among the pharmaceutical companies in Denmark, with more than 40 thousand employees.
Two other large pharmaceutical companies headquartered in the country are H. Lundbeck, focusing on pharmaceuticals for psychiatric and neurological diseases, and Leo Pharma, their main product is medication for skin diseases. Other large Danish companies are Orifarm group, ALK-Abello, and Xellia Pharmaceuticals, among others.
Most of the pharmaceutical spending in Denmark is on prescription pharmaceuticals and pharmaceuticals for impatient care. For the pharmacies, which is the main channel for pharmaceutical sales in the country, almost three fourths of the turnover come from prescription pharmaceuticals.